B&C News: Biobased Products, Biotechnology

April 5, 2016
BRAG Petition Succeeds:  EPA Expands Chemical Data Reporting Exemptions To Biodiesel Products
On March 29, 2016, the U.S. Environmental Protection Agency (EPA) published the Partial Exemption of Certain Chemical Substances from Reporting Additional Chemical Data final rule in the Federal Register. This final rule amends the list of chemical substances that are partially exempt from additional reporting requirements under the Chemical Data Reporting (CDR) rule. The rule applies to six biodiesel chemicals that are very similar to petroleum based biodiesel chemicals that are already on the exempt list. Per EPA's estimate, companies that utilize this reporting exemption will save ... read more >
March 3, 2016
Richard E. Engler Presents TSCA And The Cellulosic Revolution At ABLC2016
On February 18, 2016, Richard E. Engler, Ph.D., Senior Chemist at Bergeson & Campbell, P.C. (B&C®), presented at Cellulosic Fuels: First Commercials and Beyond, a session at the Advanced Bioeconomy Leadership Conference 2016 (ABLC2016).  Dr. Engler’s presentation, “TSCA and the Cellulosic Revolution,” covered Toxic Substances Control Act (TSCA) nomenclature, inventory, and model manufacturing process issues for cellulosic products.  The presentation discussed the differences in nomenclature between Class I and Class II substances on the TSCA Inventory, ... read more >
March 3, 2016
Kathleen M. Roberts Presents “Achieving Critical Policy Changes through Consortia” At ABLC2016
On February 19, 2016, Kathleen M. Roberts, Executive Director of the Biobased and Renewable Products Advocacy Group (BRAG®), presented “Achieving Critical Policy Changes through Consortia” at the 2016 Advanced Bioeconomy Leadership Conference (ABLC2016).  Ms. Roberts presented as part of The Bioeconomy R&D Consortia Summit and discussed the work being done by BRAG to level the regulatory playing field for biobased chemicals.  BRAG has successfully petitioned the U.S. Environmental Protection Agency (EPA) to make Chemical Data Reporting (CDR) partial reporting ... read more >
February 1, 2016
Richard E. Engler, Ph.D. Interviewed In Nature Biotechnology Article “A face-lift for biotech rules
The December 2015 issue of Nature Biotechnology included comments by Richard E. Engler, Ph.D. on keeping biotech rules current with scientific progress in the article “A face-lift for biotech rules begins.” To stay up to date with technology, Richard Engler, a senior chemist at the environmental law firm Bergeson & Campbell in Washington, DC, suggested that technology stewards be embedded in each of the relevant federal agencies. Their role would be to monitor emerging technologies and hold regular briefings with industry and academic ... read more >
November 25, 2015
Diverse Parties Say Federal Biotech Rules Confusing
The November 25, 2015, Bloomberg BNA Daily Environment Report quoted Bergeson & Campbell, P.C., in the article “Diverse Parties Say Federal Biotech Rules Confusing.” Bergeson & Campbell PC, a law firm that represents companies working with emerging technologies, supported the efforts to update the framework but described structural problems that may thwart the White House's intentions. The regulatory infrastructure is ill-suited to address synthetic biology—a new form of genetic engineering—nimbly or comprehensibly, the law firm wrote. Some synbio ... read more >
November 6, 2015
Inside EPA Includes Comments From Richard E. Engler, Ph.D. In Article “Agencies Receive Conflicting Comments On Update Of Biotech Reviews”
On November 6, 2015, Inside EPA included comments made by Richard E. Engler, Ph. D. at a public meeting held by EPA, USDA, and FDA to  update the federal coordinated framework for how the three agencies regulate biotechnology. […]Industry officials, meanwhile, emphasized biotechnology's growing importance in food production and cautioned that over-regulation will stifle innovation. Officials with Dupont and the law firm Bergeson & Campbell, P.C., which represents industry clients, called for science-based assessments that consider products' risks and ... read more >
November 2, 2015
BNA Daily Environment Report Article “New Authority Not Expected for Biotech Framework Update,” Quotes Richard E. Engler, Ph.D.
The November 2, 2015, BNA Daily Environment Report article, “New Authority Not Expected for Biotech Framework Update,” included comments made by Richard E. Engler, Ph.D. at the “Modernizing the Regulatory System for Biotechnology Products” public meeting held by FDA, USDA, and EPA.     […DuPont global director of corporate regulatory affairs Terry] Medley and Richard Engler, a senior chemist working for Bergeson & Campbell P.C., said the update needs to provide public confidence in the regulatory oversight process, so that the public can ... read more >
October 27, 2015
Lynn L. Bergeson Quoted in BNA Daily Environment Report Article “Uncertain Regulatory Path Costs Biotech Companies”
Lynn L. Bergeson was quoted in the October 15, 2015, BNA Daily Environment Report article “Uncertain Regulatory Path Costs Biotech Companies” about the recent Wilson Center report “The DNA of the U.S. Regulatory System: Are We Getting it Right for Synthetic Biology?”: Getting regulatory approval for products made with synthetic biology techniques is a daunting process, Lynn Bergeson, managing partner of Bergeson & Campbell P.C., and co-author of the report, said during the Woodrow Wilson Center's forum. “It's not clear what door do you knock on ... read more >
October 26, 2015
Inside EPA Quotes Lynn L. Bergeson in article “TSCA Reform Legislation Could Smooth Path For New Biotechnologies”
The October 26, 2015, Inside EPA article, “TSCA Reform Legislation Could Smooth Path For New Biotechnologies,” included comments made by Lynn L. Bergeson at an event hosted by the Wilson Center’s Synthetic Biology Project (synbio). Pending legislation in Congress to reform the 40-year-old Toxic Substances Control Act (TSCA) could make it easier for EPA to assess the potential risks of new technologies, such as synthetic biology, and review requests to undertake field research or commercialize new products, an industry attorney says. While the legislation does not ... read more >
October 20, 2015
Leveraging Synthetic Biology’s Promise and Managing Potential Risk
On October 15, 2015, Bergeson & Campbell, P.C. (B&C®) and the Woodrow Wilson International Center for Scholars (Wilson Center) hosted “Leveraging Synthetic Biology’s Promise and Managing Potential Risk,” a panel discussion featuring Lynn L. Bergeson, Sheryl Lindros Dolan, and Richard E. Engler, Ph.D., of B&C, and Todd Kuiken, Ph.D., Senior Program Associate, Synthetic Biology Project, Wilson Center. The event coincided with the release of “The DNA of the U.S. Regulatory System: Are We Getting It Right For Synthetic Biology?,” authored by the ... read more >
 < 1 2 3 4 5 >  Last › View 10 | 25 | 50 | 100 per page
 
BERGESON & CAMPBELL, P.C.
2200 Pennsylvania Avenue, NW, Suite 100W
Washington, D.C. 20037
202-557-3800 • 202-557-3836 (fax) | lawbc.com
Contact • Twitter
 
Privacy Policy | Terms of Use | Cookie Policy | Attorney Advertising | Trademarks
©2022 Bergeson & Campbell, P.C.
All Rights Reserved.